← Leaderboards
Bharat Bhushan
University Of Pittsburgh At Pittsburgh
$1,659,582
Attributed
$2,131,520
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $896.8K · FY2023–25$1M$750K$500K$250K$0
'23
'24
'25
Funding mix
By agency
NIH$2,131,520 · 2
By mechanism
R01$2,131,520 · 2
Top collaborators
- George K Michalopoulos2 shared
Most similar at University Of Pittsburgh At Pittsburgh
Same institution · by research overlap
- Chuanyue Wu$7,897,835
- Youhua Liu$11,880,962
- Pat R Levitt$42,762,313
- Jennifer R Grandis$109,711,044
- Reza Zarnegar$10,558,814
Research focus
CanertinibLigandsEpidermal Growth Factor ReceptorSignal TransductionMet GeneLiverLiver RegenerationPharmacologicReceptor Protein-Tyrosine KinasesInhibitorReceptorPublishingHepatocytePharmacological TreatmentGrowth Factor ReceptorsAcetaminophen OverdoseAutophagocytosisAcute Liver InjuryAcetaminophenGlutathioneAntioxidantsCessation Of LifeAcute Liver FailureAnalgesics
Grant awards (5)
Diverging roles of EGFR and MET in acetaminophen-induced acute liver injury$373,734
R01 · FY2025 · DK · contact PI
Inhibition of EGF Receptor Prevents and Reverses Non-Alcoholic Fatty Liver Disease$462,307
R01 · FY2024 · DK
Diverging roles of EGFR and MET in acetaminophen-induced acute liver injury$398,650
R01 · FY2024 · DK · contact PI
Inhibition of EGF Receptor Prevents and Reverses Non-Alcoholic Fatty Liver Disease$481,570
R01 · FY2023 · DK
Diverging roles of EGFR and MET in acetaminophen-induced acute liver injury$415,259
R01 · FY2023 · DK · contact PI